Democrats blast FDA labeling proposal
This article was originally published in The Gray Sheet
Executive Summary
Eight Democratic representatives and senators urge FDA Jan. 23 not to finalize a proposed rule in which the agency seeks to "reaffirm" the limited authority drug and device firms have in altering labels without approval (1"The Gray Sheet" Jan. 21, 2008, p. 6). The lawmakers write that the proposal is "part of a pattern of actions in the Bush administration's final months to permanently insulate the drug and device industry from liability [for unsafe products].